Bipolar I depression
bipolar II depression
approved for both

CAPLYTA is an FDA-approved treatment option for bipolar I and bipolar II depression in adults as monotherapy and adjunctive therapy with lithium or valproate.1

Attend a CAPLYTA speaker program

Watch a peer-led presentation on the CAPLYTA clinical profile

Help your patients Let in the LYTE

Help your patients Let in the LYTE

Reference: 1. CAPLYTA prescribing information.